SELLAS Life Sciences Group (SLS) Consolidated Net Income: 2011-2023
Historic Consolidated Net Income for SELLAS Life Sciences Group (SLS) over the last 4 years, with Dec 2023 value amounting to -$8.2 million.
- SELLAS Life Sciences Group's Consolidated Net Income rose 13.43% to -$8.2 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$37.9 million, marking a year-over-year increase of 9.73%. This contributed to the annual value of -$37.9 million for FY2023, which is 8.31% up from last year.
- Latest data reveals that SELLAS Life Sciences Group reported Consolidated Net Income of -$8.2 million as of Q4 2023, which was up 12.65% from -$9.4 million recorded in Q3 2023.
- SELLAS Life Sciences Group's 5-year Consolidated Net Income high stood at -$2.2 million for Q1 2021, and its period low was -$16.7 million during Q1 2022.
- For the 3-year period, SELLAS Life Sciences Group's Consolidated Net Income averaged around -$8.8 million, with its median value being -$8.8 million (2022).
- Per our database at Business Quant, SELLAS Life Sciences Group's Consolidated Net Income skyrocketed by 44.76% in 2021 and then plummeted by 645.43% in 2022.
- Over the past 4 years, SELLAS Life Sciences Group's Consolidated Net Income (Quarterly) stood at -$4.2 million in 2020, then slumped by 179.37% to -$11.6 million in 2021, then grew by 18.70% to -$9.4 million in 2022, then climbed by 13.43% to -$8.2 million in 2023.
- Its last three reported values are -$8.2 million in Q4 2023, -$9.4 million for Q3 2023, and -$9.1 million during Q2 2023.